Freed Targets Shrinking Small Practices

Freed is winning in the easiest part of the scribe market, but that part of the market gets smaller as care shifts into larger organizations. Its $99 per clinician self serve motion works best when one doctor or a tiny group can buy software on their own, yet those practices face the most financial pressure and are steadily selling to hospitals, insurers, and private equity backed groups. That makes Freed’s distribution advantage real today, but less durable over time.1 2 3 4 5

• Small practice adoption is fast because the user is also the buyer. Freed grew by selling directly to individual clinicians and practices with fewer than 10 doctors, a segment estimated at 47% of U.S. small practices. But this same segment has limited seat expansion, tight budgets, and high churn into larger groups.1 2 3
• The technical burden rises as Freed moves upmarket. In small practices, copy paste and lighter workflows can be enough at first. In larger groups, scribes need deeper EHR integration so the software can place notes, diagnoses, orders, and coding data inside the record, and that turns into an IT led enterprise sale across a fragmented long tail of outpatient EHRs.1 3 4
• Enterprise rivals are taking the consolidating end of the market. Abridge used Epic and Athenahealth partnerships to reach 60,000 plus clinicians across 100 plus health systems, while Epic kept growing acute care hospital share to 43.7% in 2025. As more doctors move into system owned settings, the default vendor increasingly gets chosen at the health system level, not by the individual doctor.4 6 7

The next phase is a race to turn a lightweight note tool into a system level workflow product. Freed can keep growing by adding coding, pre charting, and front desk tools around the visit, but the companies that control deeper EHR integrations and enterprise procurement will be best positioned as consolidation keeps moving doctors out of independent practice.1 3 4 5 6 7